ELDECALCITOL REDUCES THE RISK OF SEVERE VERTEBRAL FRACTURES AND IMPROVES THE QUALITY OF LIFE IN PATIENTS WITH OSTEOPOROSIS

被引：0
|
作者：
Hagino, H. [1 ]
Takano, T. [2 ]
Fukunaga, M. [3 ]
Shiraki, M. [4 ]
Nakamura, T. [5 ]
Matsumoto, T. [6 ]
机构：
[1] Tottori Univ, Yonago, Tottori, Japan
[2] Chugai Pharmaceut Co Ltd, Tokyo, Japan
[3] Kawasaki Med Sch, Kurashiki, Okayama, Japan
[4] Res Inst & Practice Involut Dis, Azumino, Japan
[5] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan
[6] Univ Tokushima, Grad Sch Med Sci, Tokushima 770, Japan
来源：
OSTEOPOROSIS INTERNATIONAL | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S818 / S818
页数：1
相关论文
共 50 条
  • [1] Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis
    Hiroshi Hagino
    Toshiyuki Takano
    Masao Fukunaga
    Masataka Shiraki
    Toshitaka Nakamura
    Toshio Matsumoto
    [J]. Journal of Bone and Mineral Metabolism, 2013, 31 : 183 - 189
  • [2] Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis
    Hagino, Hiroshi
    Takano, Toshiyuki
    Fukunaga, Masao
    Shiraki, Masataka
    Nakamura, Toshitaka
    Matsumoto, Toshio
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2013, 31 (02) : 183 - 189
  • [3] Teriparatide reduces the Risk of new Vertebral Body Fractures in severe Osteoporosis
    Ruchalla, Elke
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (10) : 696 - 697
  • [4] EVALUATION OF THE RELATIONSHIP BETWEEN VERTEBRAL FRACTURES AND QUALITY OF LIFE IN PATIENTS WITH OSTEOPOROSIS
    Demirdal, U. S.
    Gokce, I.
    Solak, O.
    Toktas, H.
    Dundar, U.
    Kavuncu, V.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 116 - 117
  • [5] The impact of vertebral fragility fractures on health related quality of life in patients with osteoporosis
    ElMiedany, Y.
    Gardienr, A.
    Toth, M.
    [J]. RHEUMATOLOGY, 2007, 46 : I126 - I126
  • [6] Quality of Life in Patients with Vertebral Fractures: Validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO)
    P. Lips
    C. Cooper
    D. Agnusdei
    F. Caulin
    P. Egger
    O. Johnell
    J. A. Kanis
    S. Kellingray
    A. Leplege
    U. A. Liberman
    E. McCloskey
    H. Minne
    J. Reeve
    J.-Y. Reginster
    M. Scholz
    C. Todd
    M. C. de Vernejoul
    I. Wiklund
    [J]. Osteoporosis International, 1999, 10 : 150 - 160
  • [7] Quality of life in patients with vertebral fractures: Validation of the quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO)
    Lips, P
    Cooper, C
    Agnusdei, D
    Caulin, F
    Egger, P
    Johnell, O
    Kanis, JA
    Kellingray, S
    Leplege, A
    Liberman, UA
    McCloskey, E
    Minne, H
    Reeve, J
    Reginster, JY
    Scholz, M
    Todd, C
    de Vernejoul, MC
    Wiklund, I
    [J]. OSTEOPOROSIS INTERNATIONAL, 1999, 10 (02) : 150 - 160
  • [8] Quality of life in patients with vertebral fractures
    Lips, P
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S2 - S3
  • [9] Teriparatide reduces vertebral height loss in women with osteoporosis and severe prevalent vertebral fractures.
    Genant, HK
    Prevrhal, S
    Crans, GG
    Glass, EV
    Krege, JH
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S409 - S409
  • [10] Association of severe vertebral fractures with reduced quality of life - Reduction in the incidence of severe vertebral fractures by teriparatide
    Crans, GG
    Silverman, SL
    Genant, HK
    Glass, EV
    Krege, JH
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4028 - 4034
12345